These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25263095)

  • 1. Prognostic value of enzymatic liver function for the estimation of short-term survival of liver transplant candidates: a prospective study with the LiMAx test.
    Jara M; Malinowski M; Lüttgert K; Schott E; Neuhaus P; Stockmann M
    Transpl Int; 2015 Jan; 28(1):52-8. PubMed ID: 25263095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combination of MELD score and ICG liver testing predicts length of stay in the ICU and hospital mortality in liver transplant recipients.
    Klinzing S; Brandi G; Stehberger PA; Raptis DA; Béchir M
    BMC Anesthesiol; 2014; 14():103. PubMed ID: 25844060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of indocyanine green clearance and model for end-stage liver disease for estimation of short-term prognosis in decompensated cirrhosis.
    Stauber RE; Wagner D; Stadlbauer V; Palma S; Gurakuqi G; Kniepeiss D; Iberer F; Smolle KH; Haas J; Trauner M
    Liver Int; 2009 Nov; 29(10):1516-20. PubMed ID: 19732329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Assessment of Liver Function by an Enzymatic Liver Function Test to Estimate Short-Term Survival in Patients with Liver Cirrhosis.
    Jara M; Dziodzio T; Malinowski M; Lüttgert K; Nikolov R; Ritschl PV; Öllinger R; Pratschke J; Stockmann M
    Dig Dis Sci; 2019 Feb; 64(2):576-584. PubMed ID: 30406480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could metabolic liver function tests predict mortality on waiting list for liver transplantation? A study on 560 patients.
    Ecochard M; Boillot O; Guillaud O; Roman S; Adham M; Mion F; Dumortier J
    Clin Transplant; 2011; 25(5):755-65. PubMed ID: 21158918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the prognosis in acute liver failure: results from a retrospective pilot study using the LiMAx test.
    Lock JF; Kotobi AN; Malinowski M; Schulz A; Jara M; Neuhaus P; Stockmann M
    Ann Hepatol; 2013; 12(4):556-62. PubMed ID: 23813133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early diagnosis of sepsis-related hepatic dysfunction and its prognostic impact on survival: a prospective study with the LiMAx test.
    Kaffarnik MF; Lock JF; Vetter H; Ahmadi N; Lojewski C; Malinowski M; Neuhaus P; Stockmann M
    Crit Care; 2013 Oct; 17(5):R259. PubMed ID: 24172237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limitations of use of the noninvasive clearance of indocyanine green as a prognostic indicator of graft function in liver transplantation.
    Escorsell À; Mas A; Fernández J; García-Valdecasas JC
    Transplant Proc; 2012; 44(6):1539-41. PubMed ID: 22841207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early diagnosis of primary nonfunction and indication for reoperation after liver transplantation.
    Lock JF; Schwabauer E; Martus P; Videv N; Pratschke J; Malinowski M; Neuhaus P; Stockmann M
    Liver Transpl; 2010 Feb; 16(2):172-80. PubMed ID: 20104485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the methacetin breath test to classify the risk of cirrhotic complications and mortality in patients evaluated/listed for liver transplantation.
    Stravitz RT; Reuben A; Mizrahi M; Lalazar G; Brown K; Gordon SC; Ilan Y; Sanyal A
    J Hepatol; 2015 Dec; 63(6):1345-51. PubMed ID: 26220750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indocyanine green plasma disappearance rate: a new tool for the classification of paediatric patients with acute liver failure.
    Quintero J; Miserachs M; Ortega J; Bueno J; Dopazo C; Bilbao I; Castells L; Charco R
    Liver Int; 2014 May; 34(5):689-94. PubMed ID: 24112412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting immunosuppressant dosing in the early postoperative period with noninvasive indocyanine green elimination following orthotopic liver transplantation.
    Parker BM; Cywinski JB; Alster JM; Irefin SA; Popovich M; Beven M; Fung JJ
    Liver Transpl; 2008 Jan; 14(1):46-52. PubMed ID: 18161838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assessment of the predictive value of the model for end-stage liver disease scoring system combined with the indocyanine green clearance test for short-term prognosis of acute-on-chronic hepatitis B liver failure].
    Tang K; Shan J; Tian F; Cao W
    Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):190-4. PubMed ID: 24824120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired functional capacity in potential liver transplant candidates predicts short-term mortality before transplantation.
    Ow MM; Erasmus P; Minto G; Struthers R; Joseph M; Smith A; Warshow UM; Cramp ME; Cross TJ
    Liver Transpl; 2014 Sep; 20(9):1081-8. PubMed ID: 24805969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oxaliplatin-based chemotherapy on liver function--an analysis of impact and functional recovery using the LiMAx test.
    Jara M; Bednarsch J; Malinowski M; Pratschke J; Stockmann M
    Langenbecks Arch Surg; 2016 Feb; 401(1):33-41. PubMed ID: 26507639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporating indocyanin green clearance into the Model for End Stage Liver Disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis.
    Zipprich A; Kuss O; Rogowski S; Kleber G; Lotterer E; Seufferlein T; Fleig WE; Dollinger MM
    Gut; 2010 Jul; 59(7):963-8. PubMed ID: 20581243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The value of the baseline MELD scores, MELD-Na scores and iMELD scores in short-term prognosis in hepatitis B virus related acute-on-chronic liver failure patients].
    Li C; You S; Liu H; Liu W; Wan Z; Tang G; Xin S
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Aug; 26(8):539-43. PubMed ID: 25124900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Measurement of Indocyanine Green Clearance Accurately Predicts Short-Term Outcomes After Liver Transplantation.
    Olmedilla L; Lisbona CJ; Pérez-Peña JM; López-Baena JA; Garutti I; Salcedo M; Sanz J; Tisner M; Asencio JM; Fernández-Quero L; Bañares R
    Transplantation; 2016 Mar; 100(3):613-20. PubMed ID: 26569066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity.
    Stockmann M; Lock JF; Riecke B; Heyne K; Martus P; Fricke M; Lehmann S; Niehues SM; Schwabe M; Lemke AJ; Neuhaus P
    Ann Surg; 2009 Jul; 250(1):119-25. PubMed ID: 19561474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of adult liver re-transplant patients in the model for end-stage liver disease era: is it time to reconsider its indications?
    Montenovo MI; Hansen RN; Dick AA
    Clin Transplant; 2014 Oct; 28(10):1099-104. PubMed ID: 25041109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.